• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On October 20, AstraZeneca and Japanese pharmaceutical company Daiichi Sankyos anti-cancer drug Enhertu brought better treatment results for patients with early breast cancer. In two key trials presented at the European Society for Oncology meeting held in Berlin last weekend, Enhertu performed better than Roches Kadcyla in preventing the disease from coming back and was more effective when used before surgery.Amazon (AMZN.O) shares fell about 0.4% in pre-market trading after Amazon Web Services (AWS) said it was investigating increased error rates and latency in multiple AWS services in the U.S. East 1 region.Sources: The Bank of Japan is likely to maintain its view that the economy will recover steadily despite headwinds from U.S. tariffs.Sources: The Bank of Japan may slightly raise its economic growth forecast for fiscal 2025 at its October policy meeting.On October 20th, the Raw Materials Industry Department of the Ministry of Industry and Information Technology held a symposium on stabilizing growth in the cement industry. The symposium emphasized the need to accelerate the implementation of the "Work Plan for Stabilizing Growth in the Building Materials Industry (2025-2026)," continuously improve the quality and efficiency of industries like cement, and promote stable operation and structural optimization and upgrading. The meeting emphasized the importance of recognizing the prominent contradictions between supply and demand in the cement industry. With the goal of promoting a dynamic balance between supply and demand and industrial transformation and upgrading, and with marketization and the rule of law as the fundamental direction, the meeting emphasized the importance of upholding and consolidating the industry through reform and innovation, prioritizing the current situation while focusing on the long term. New production capacity must be strictly prohibited, existing capacity must be standardized, and outdated capacity must be eliminated. The meeting emphasized the importance of key enterprises playing a leading and driving role, strictly implementing policies such as cement capacity replacement and capacity standardization. By the end of 2025, capacity replacement plans must be developed for capacity exceeding project filings to ensure consistency between actual and filed capacity.

U.S. crude oil trading strategy on October 12: Continue to be optimistic about rising oil prices

Oct 26, 2021 11:02

On Tuesday (October 12), US crude oil held steady above 80. Short-term bulls are still very strong. Investors are advised to continue to do more on dips.


Daily level: Although oil prices surged and fell on Monday, the bulls were still strong, and there was no change in the pattern of tight fundamentals. Investment banks predicted that oil prices would rise to the 90 mark.

In terms of technical indicators, RSI shows an overbought signal, but it does not seem to be enough to stop the bulls’ madness. At present, there is no obvious topping signal. Investors are advised not to go short against the trend.

In general, there are still great opportunities for the upside, and it is recommended that investors continue to do more on dips.

The upper resistance is mainly concerned with the pressure of each integer mark, and the lower support is concerned with the 5-day moving average of 79.32, the 10-day moving average of 77.89 and the July 6 high of 76.98.

(U.S. crude oil daily chart)

Resistance levels: 81.00; 82.18; 83.00
Support levels: 79.32; 77.89; 76.98

Short-term operation advice: do more on dips.

At 14:39 GMT+8, US crude oil was quoted at US$80.55 per barrel.